ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $196 | -11.7% | 7,200 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $222 | -14.6% | 7,200 | 0.0% | 0.01% | -23.1% |
| Q1 2023 | $260 | -8.5% | 7,200 | 0.0% | 0.01% | -13.3% |
| Q4 2022 | $284 | -99.9% | 7,200 | 0.0% | 0.02% | -6.2% |
| Q3 2022 | $289,000 | -4.3% | 7,200 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $302,000 | -6.8% | 7,200 | -13.3% | 0.02% | +14.3% |
| Q1 2022 | $324,000 | -2.1% | 8,300 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $331,000 | +10.3% | 8,300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $300,000 | -11.8% | 8,300 | 0.0% | 0.01% | -13.3% |
| Q2 2021 | $340,000 | – | 8,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |